Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida, USA.
Research Center in Minority Institutions, Florida International University, Miami, Florida, USA.
AIDS Patient Care STDS. 2024 Sep;38(9):393-427. doi: 10.1089/apc.2024.0097. Epub 2024 Jul 26.
The COVID-19 virus, once a public health emergency, is now endemic. Immunization remains an important measure for mitigating high levels of disease, morbidity, and mortality related to COVID-19 infection. People with HIV (PWH), in particular, benefit from COVID-19 vaccination because of increased risk for severe COVID-19 infection. However, previous data suggest vaccine hesitancy among this population. Given this context and the evolving epidemiology of COVID-19, this review examines factors associated with COVID-19 vaccine hesitancy, acceptability, and uptake among adults with HIV. Through a systematic search of electronic databases, we identified 56 peer-reviewed articles published between the years 2020 and 2023 that matched the objectives of our review out of a total of 797 screened citations. Among our final sample of articles, nearly all global regions were represented, and 61% of studies recruited only PWH. We identified eight categories of factors associated with COVID-19 vaccination outcomes, including HIV-specific factors (e.g., CD4 count), vaccine attitudes (e.g., vaccine confidence), factors related to the COVID-19 virus (e.g., concern about infection), factors specific to the COVID-19 vaccine (e.g., accessibility), social norms and peer factors (e.g., subjective norms), mental health (e.g., anxiety/depression) and other psychological factors (e.g., substance use), demographic characteristics (e.g., age), and health factors (e.g., vaccination history). Reflecting on these factors, we discuss populations in need of vaccine promotion, modifiable targets for intervention, and integrating immunization into HIV care. Public health efforts to promote COVID-19 immunization among PWH must include educational/informational, peer, and structural interventions and must now consider uptake of COVID-19 booster doses.
新冠病毒(COVID-19)曾是一场公共卫生紧急事件,现已成为地方病。免疫接种仍然是减轻与 COVID-19 感染相关的高疾病、发病率和死亡率的重要措施。特别是艾滋病毒感染者(PWH),由于感染 COVID-19 后出现严重疾病的风险增加,因此受益于 COVID-19 疫苗接种。然而,此前的数据表明该人群中存在疫苗犹豫。鉴于这一背景和 COVID-19 的不断演变的流行病学,本综述检查了与 HIV 成人中 COVID-19 疫苗犹豫、可接受性和接种相关的因素。通过对电子数据库的系统搜索,我们从总共筛选出的 797 篇引用文献中,确定了 2020 年至 2023 年期间发表的 56 篇符合本综述目的的同行评审文章。在我们的最终文章样本中,几乎所有全球地区都有代表,61%的研究仅招募了 PWH。我们确定了与 COVID-19 疫苗接种结果相关的八类因素,包括与 HIV 相关的因素(例如,CD4 计数)、疫苗态度(例如,疫苗信心)、与 COVID-19 病毒相关的因素(例如,对感染的担忧)、与 COVID-19 疫苗相关的因素(例如,可及性)、社会规范和同伴因素(例如,主观规范)、心理健康(例如,焦虑/抑郁)和其他心理因素(例如,药物使用)、人口统计学特征(例如,年龄)和健康因素(例如,疫苗接种史)。在考虑到这些因素的基础上,我们讨论了需要疫苗推广的人群、可干预的目标以及将免疫接种纳入 HIV 护理。促进 PWH 接种 COVID-19 疫苗的公共卫生工作必须包括教育/信息、同伴和结构干预措施,现在还必须考虑接种 COVID-19 加强针。